Shareholding19 Aug 2026, 11:18 am
Sudhir Sethi Acquires 0.06% Stake in Beryl Drugs
AI Summary
Sudhir Sethi, a promoter of Beryl Drugs Ltd, has acquired 3,000 equity shares, representing 0.06% of the total share capital. This acquisition was made through market transactions. Following the purchase, Sethi's total shareholding in Beryl Drugs increased to 514,119 shares, which constitutes 10.14% of the company's total voting capital. The total equity share capital of the company remains at 50,71,700 shares.
Key Highlights
- Promoter Sudhir Sethi acquired 3,000 shares.
- Acquisition represents 0.06% of total share capital.
- Sethi's total holding now stands at 10.14%.
- Acquisition was made via market transactions.
Price Impact
More from BERLDRG